122 related articles for article (PubMed ID: 5721531)
1. Studies on measles in Thailand. 3. Field trials on measles vaccine.
Tuchinda P; Sangkawibha N; Ueda S; Okuno Y; Bukkavesa S
Biken J; 1968 Dec; 11(4):251-9. PubMed ID: 5721531
[No Abstract] [Full Text] [Related]
2. Studies on measles in Thailand. V. Protection against a measles outbreak by previous vaccination in an isolated institution.
Sangkawibha N; Tuchinda P; Bukkavesa S; Osatanonda P; Ueda S; Okuno Y
Biken J; 1971 Dec; 14(4):413-7. PubMed ID: 5149999
[No Abstract] [Full Text] [Related]
3. Studies on measles in Thailand. II. Field trials of measles vaccine, with special reference to the K-L method.
Tsuchinda P; Jayavasu J; Sangkawibha N; Okuno Y; Ueda S
Biken J; 1967 Sep; 10(3):135-41. PubMed ID: 6081222
[No Abstract] [Full Text] [Related]
4. Studies on measles in Thailand. VI. A clinical trial of "CAM 70" measles virus vaccine in home-dwelling children.
Sangkawibha N; Ueda S; Tuchinda P; Sakuntanaga P; Sunthonsaratul A
Biken J; 1973 Dec; 16(4):167-71. PubMed ID: 4799209
[No Abstract] [Full Text] [Related]
5. Studies on measles in Thailand. IV. Persistence of measles antibody in the absence of natural virus two years after vaccination by the "KL" method.
Sangkawibha N; Tsuchida P; Bukkavesa S; Ostanonda P; Ueda S
Biken J; 1971 Jun; 14(2):149-54. PubMed ID: 5122205
[No Abstract] [Full Text] [Related]
6. Studies on further attenuated live measles vaccine. VIII. Estimated duration of immunity after vaccination without natural infection.
Ueda S; Okuno Y; Sakamoto Y; Sangkawibha N; Tuchinda P
Biken J; 1974 Mar; 17(1):11-20. PubMed ID: 4854462
[No Abstract] [Full Text] [Related]
7. Studies on further attenuated liver measles vaccine. VI. Clinical and serological follow-up one year after vaccination.
Ueda S; Takahashi M; Kurimura T; Suzuki N; Yamanishi K
Biken J; 1971 Sep; 14(3):247-51. PubMed ID: 4258008
[No Abstract] [Full Text] [Related]
8. Studies on the combined use of killed and live measles vaccines. IV. Fou years follow-up.
Ueda S; Takahashi M; Hosai H; Yamanishi K; Okuno Y
Biken J; 1969 Jun; 12(2):69-75. PubMed ID: 5346351
[No Abstract] [Full Text] [Related]
9. [On the simultaneous use of live-virus vaccines, for example measles-polio vaccine].
Böthig B; Gerike E; Starke G; Giesecke H
Rev Roum Virol (1972); 1974; 25(1):15-21. PubMed ID: 4410266
[No Abstract] [Full Text] [Related]
10. [Evaluation of the vaccination of a misture of inactivated and live measles vaccines. 1. Clinicoserological observation for a period of 4 years].
Tanaka H
Nihon Shonika Gakkai Zasshi; 1972 Mar; 76(3):162-9. PubMed ID: 5065657
[No Abstract] [Full Text] [Related]
11. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus.
Takaku K; Sasada T; Konobe T; Onishi K; Ueda S
Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510
[No Abstract] [Full Text] [Related]
12. Vaccination against measles: a clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. A report to the Medical Research Council by the Measles Vaccines Committee.
Br Med J; 1966 Feb; 1(5485):441-6. PubMed ID: 5902680
[No Abstract] [Full Text] [Related]
13. Measles vaccination coverage during poliomyelitis national immunization days in Burkina Faso, 1999.
Yaméogo KR; Yaméogo A; Nacoulma SD; Zuber PL
J Infect Dis; 2003 May; 187 Suppl 1():S74-9. PubMed ID: 12721895
[TBL] [Abstract][Full Text] [Related]
14. Investigation and application of the USSR AMS live measles vaccine from the ESC strain for mass vacceination against measles.
Chumakov MP; Voroshilova MK; Grachev VP; Sinyak KM; Boiko VM; Seibil VB; Rodin VI; Piven GG
Arch Roum Pathol Exp Microbiol; 1969; 28(2):651-67. PubMed ID: 5400784
[No Abstract] [Full Text] [Related]
15. Studies on the combined use of killed and live measles vaccines. V. Five year follow-up.
Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N
Biken J; 1970 Sep; 13(3):179-83. PubMed ID: 5496091
[No Abstract] [Full Text] [Related]
16. [Studies of specific measles prevention].
Cajal N; Cepleanu M; Sorodoc Y; Cernescu C; Manu S; Weintraub B; Lucian M; Popescu M
Stud Cercet Inframicrobiol; 1970; 21(3):195-211. PubMed ID: 5455840
[No Abstract] [Full Text] [Related]
17. Development of extremely attenuated live measles virus vaccine (CAM-EX).
Ueda S; Takahashi M; Kurimura T; Minekawa Y; Suzuki N
Biken J; 1972 Sep; 15(3):173-7. PubMed ID: 4643692
[No Abstract] [Full Text] [Related]
18. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
[TBL] [Abstract][Full Text] [Related]
19. [Measles vaccination: study of humoral immunity in children vaccinated in the Tunis region].
Arrouji A; Mirchamsy H; Marnissi A
Arch Inst Pasteur Tunis; 1982 Mar; 59(1):173-80. PubMed ID: 7181563
[No Abstract] [Full Text] [Related]
20. [Mass vaccination against measles in the Republic of Guatemala, 1972. Evaluation of the campaign].
Mata LJ; Aguilar FJ; Eddins DL; Herrmann KL; Nakano JH; Aguilar JR
Bol Med Hosp Infant Mex; 1974; 31(3):505-17. PubMed ID: 4433406
[No Abstract] [Full Text] [Related]
[Next] [New Search]
